Total Payments
$8,924
2024 Payments
$1,027
Companies
51
Transactions
444
Medicare Patients
10,842
Medicare Billing
$801,514
Payment Breakdown by Category
Food & Beverage$7,878 (88.3%)
Education$1,046 (11.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,878 | 421 | 88.3% |
| Education | $1,046 | 23 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,201 | 90 | $0 (2023) |
| Janssen Biotech, Inc. | $945.34 | 60 | $0 (2024) |
| PFIZER INC. | $543.32 | 41 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $520.74 | 28 | $0 (2024) |
| Rochester Medical Corporation | $383.04 | 21 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $377.40 | 18 | $0 (2024) |
| ABBVIE INC. | $344.43 | 18 | $0 (2024) |
| Amgen Inc. | $323.64 | 7 | $0 (2024) |
| Blue Earth Diagnostics Limited | $297.41 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $279.93 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,027 | 36 | Amgen Inc. ($156.04) |
| 2023 | $1,050 | 48 | C. R. Bard, Inc. & Subsidiaries ($298.78) |
| 2022 | $1,290 | 60 | Rochester Medical Corporation ($234.45) |
| 2021 | $1,036 | 59 | Janssen Biotech, Inc. ($214.92) |
| 2020 | $351.58 | 22 | Rochester Medical Corporation ($92.67) |
| 2019 | $1,768 | 78 | Astellas Pharma US Inc ($280.72) |
| 2018 | $1,520 | 65 | Astellas Pharma US Inc ($316.96) |
| 2017 | $881.78 | 76 | Astellas Pharma US Inc ($322.70) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | C. R. Bard, Inc. & Subsidiaries | Personal Catheter Intermittent Catheter (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Urology | ||||||
| 10/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 10/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/19/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: UROLOGY | ||||||
| 07/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Oncology | ||||||
| 06/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/20/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Diagnostic Imaging | ||||||
| 06/19/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Continence Care | ||||||
| 05/29/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diagnostic Imaging | ||||||
| 05/23/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 05/15/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/25/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 04/15/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,682 | 4,135 | $664,357 | $199,260 |
| 2022 | 22 | 2,706 | 4,193 | $697,544 | $204,029 |
| 2021 | 23 | 2,767 | 4,234 | $673,692 | $204,965 |
| 2020 | 21 | 2,687 | 4,107 | $683,906 | $193,260 |
Total Patients
10,842
Total Services
16,669
Medicare Billing
$801,514
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 835 | 1,332 | $187,812 | $83,654 | 44.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 130 | $77,480 | $17,557 | 22.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 125 | 397 | $30,966 | $15,099 | 48.8% |
| 52281 | Dilation of urethra using an endoscope | Facility | 2023 | 118 | 119 | $89,250 | $12,758 | 14.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 105 | 120 | $32,400 | $11,473 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 120 | $24,960 | $11,122 | 44.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 24 | 32 | $38,056 | $10,091 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 104 | 104 | $21,736 | $8,049 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 88 | $12,496 | $5,237 | 41.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 35 | 38 | $45,797 | $4,373 | 9.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 756 | 1,084 | $6,504 | $3,659 | 56.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 72 | $12,354 | $3,219 | 26.1% |
| 52001 | Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | Facility | 2023 | 12 | 13 | $12,870 | $2,762 | 21.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 43 | 48 | $25,014 | $2,527 | 10.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 24 | 25 | $14,675 | $2,281 | 15.5% |
| 51726 | Complex measurement of pressure of urine flow in bladder | Facility | 2023 | 30 | 30 | $6,728 | $1,199 | 17.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 40 | $2,440 | $999.60 | 41.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 62 | $2,356 | $985.37 | 41.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 118 | 134 | $5,630 | $915.97 | 16.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 23 | 24 | $1,608 | $593.28 | 36.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 29 | 29 | $5,423 | $412.38 | 7.6% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 93 | 94 | $7,802 | $295.23 | 3.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 799 | 1,243 | $175,263 | $76,835 | 43.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 20 | 149 | $88,804 | $20,808 | 23.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 168 | 190 | $51,300 | $18,391 | 35.8% |
About Dr. Steven Ariss, MD
Dr. Steven Ariss, MD is a Urology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720085566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Ariss, MD has received a total of $8,924 in payments from pharmaceutical and medical device companies, with $1,027 received in 2024. These payments were reported across 444 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($7,878).
As a Medicare-enrolled provider, Ariss has provided services to 10,842 Medicare beneficiaries, totaling 16,669 services with total Medicare billing of $801,514. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Toledo, OH
- Active Since 07/07/2005
- Last Updated 05/31/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1720085566
Products in Payments
- ERLEADA (Drug) $676.80
- PROVENGE (Drug) $520.74
- XTANDI (Drug) $504.07
- Myrbetriq (Drug) $336.98
- ELIQUIS (Drug) $336.22
- Bard Urinary Drainage Bag (Device) $298.78
- ELIGARD (Drug) $290.86
- ORGOVYX (Drug) $284.58
- ZYTIGA (Drug) $277.96
- XIAFLEX (Biological) $267.17
- Vascepa (Drug) $216.66
- Axumin (Drug) $205.38
- Erleada (Drug) $205.23
- VRAYLAR (Drug) $183.74
- MYRBETRIQ (Drug) $178.11
- Epclusa (Drug) $177.29
- Nubeqa (Drug) $171.84
- XARELTO (Drug) $164.28
- EVENITY (Biological) $156.04
- Saxenda (Drug) $155.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Toledo
Dr. Salvador Peron, M.d, M.D
Urology — Payments: $19,792
Urology $19,792
Dr. Saleem Zafar, M.d, M.D
Urology — Payments: $12,409
Urology $12,409
Firas Petros, M.d, M.D
Urology — Payments: $12,016
Urology $12,016
Dr. Carin Hopps, M.d, M.D
Urology — Payments: $8,723
Urology $8,723
Philip Wong, Md, MD
Urology — Payments: $8,545
Urology $8,545
Daniel Murtagh, Md, MD
Urology — Payments: $7,257
Urology $7,257